Navigation Links
Leukodystrophy in Medical Technology

Shire Enhances its Orphan Drug Pipeline With the Acquisition of a New Clinical Candidate for Metachromatic Leukodystrophy

... Replacement Therapy (ERT) in Phase 1-2 clinical trials for Metachromatic leukodystrophy (MLD) from the Danish company Zymenex A/S (Zymenex). MLD is a serious, ... Scriver et al 1995 Notes to editors Disease Background Metachromatic leukodystrophy (MLD) is in the family of lysosomal storage diseases (LSD's). MLD is an ...

AIMSPRO is Awarded TGA Orphan Status for the Treatment of Amyotrophic Lateral Sclerosis

... form of Motor Neuron Disease (MND), also known as Lou Gehrig's disease. AIMSPRO has already achieved TGA Orphan Status for the treatment of Krabbe leukodystrophy (Krabbe's disease). Daval is now evaluating an international, multi-centre, placebo controlled, Randomised Clinical Trial to determine whether later ...
Leukodystrophy in Medical Definition

Pathology

... GM1 gangliosidoses - Mucolipidosis type IV - Gaucher's disease - Niemann-Pick disease - Farber disease - Fabry's disease - Metachromatic leukodystrophy - Krabbe disease Neuronal ceroid lipofuscinosis ( Batten disease ) - Cerebrotendineous xanthomatosis - Cholesteryl ester storage disease ( ...
Leukodystrophy in Medical Dictionary

Leukodystrophy

... Adreno leukodystrophy Dr Trisha Macnair Adreno leukodystrophy (ALD) is a rare inherited disorder that leads ... death . Take a look at the causes. Adreno leukodystrophy describes any of several closely related ...

Cml

... - chronic lymph ocytic (CLL) Leukemia - hairy cell Leukemia - nonlymphocytic (ANLL) Leukemic reticuloendotheliosis Leukemoid reaction leukodystrophy - metachromatic Leukoplakia Lewy body dementia ... Previously approved for the treatment of patients with chronic myeloid leukemia ( ...

Metabolic Diseases

... sugar found in milk ( lactose ) can lead to accumulation of another sugar called galactitol, ... Storage or metabolic diseases Ad renal leukodystrophy (ALD) Gaucher's disease Hurler's syndrome Mucopolysaccharidoses (MPS) ... Adults and children over 6 months of age who need regular ...

Mixed tension migraine

... Mixed tension migraine Alternative Names: Headache - mixed tension migraine Treatment : ... Mixed Tension Migraine MLD (Metachromatic leukodystrophy ) MMK (Surgeries for Female Stress Incontinence ) MMR - Vaccine Molar Pregnancy ( Hydatidiform Mole ) ... Migraine without aura (no ...

Molar pregnancy

... : Can a mom's depression affect her baby? Postpartum thyroiditis Pre- ejaculation fluid: Can it cause pregnancy ? MLD (Metachromatic leukodystrophy ) Molar Pregnancy ( Hydatidiform Mole ) Mole ( Birthmarks - Pigmented) Molluscum Contagiosum Mongolian Blue Spots ... age younger than 20 ...

Molluscum contagiosum

... vulgaris, verruca plantar is, HPV, acrochordon, molluscum contagiosum , seborrheic keratosis , and verruca plana; ... MLD (Metachromatic leukodystrophy ) Molar Pregnancy ( Hydatidiform Mole ) Mole ( Birthmarks - Pigmented) Molluscum Contagiosum Mongolian Blue Spots ... CRYOTHERAPY: Using ...
Leukodystrophy in Biological Technology

Shire's New Product Portfolio Delivers Strong Quarterly Performance

... Shire's US development plan and to strengthen the chances of regulatory and commercial success in the US. METAZYM (HGT-1111) - Metachromatic leukodystrophy ("MLD") - Shire has an ongoing enzyme replacement therapy program for the treatment of MLD, which is a lysosomal storage disorder that results ...

Shire Delivers Strong Quarter: Driven by $243m of New Product Sales (+164% YOY Growth). Revenue Guidance Upgrade.

... It is anticipated that this development program will support global filings in the second half of 2009. METAZYM (HGT-1111) - Metachromatic leukodystrophy ("MLD") - METAZYM is being investigated for the treatment of MLD and has completed a Phase 1b clinical trial in twelve patients in Europe and an ...

Following a Good Start to the Year Shire Reaffirms Full Year 2008 Financial Guidance

... rights to the clinical candidate arylsulfatase-A ("ASA"), currently known as METAZYM(TM), being investigated for the treatment of Metachromatic leukodystrophy ("MLD"). MLD is caused by a deficiency in the enzyme ASA which causes an excess concentration of sufatide in cells and an ensuing breakdown of ....
Other Contents
(Date:7/30/2015)... ... July 30, 2015 , ... ... at the annual All-Stars Summit. Google Partners is the platform for search marketing ... the full support and tools necessary to run successful search marketing campaigns. Google ...
(Date:7/30/2015)... ... , ... Quintessa Medical Spa is happy to offer patients the latest treatment ... for the elimination of excess tissue under the chin, referred to as submental fat. ... to offer this innovative treatment. , Developed by Kythera Biopharmaceuticals, Kybella was approved by ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American ... Chuck Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. The ... from 10:00 AM to 2:00 PM local time. On the 26th, the DEA, ...
(Date:7/30/2015)... Raleigh, NC (PRWEB) , ... July 30, 2015 , ... ... older patients. Click here to read more on the Surviving Mesothelioma website. ... Orthopedic Rehabilitation Hospital in Missouri reviewed more than 12,000 cases of mesothelioma occurring between ...
(Date:7/30/2015)... ... 30, 2015 , ... 1Heart Caregiver Services LLC is offering its 1st Business ... in the Booming Homecare Business.” This will be held in its main headquarters at ... event will be hosted by 1Heart’s very own Randy Clarito (Director of Business and ...
Breaking Medicine News(10 mins):Health News:Boston Web Marketing Attends Google Partners All-Stars Summit 2Health News:Quintessa MedSpa Offers Nonsurgical Double-chin Elimination 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3Health News:Study Finds Mesothelioma Behaves Differently in Younger People, According to Surviving Mesothelioma 2Health News:Upcoming Business Seminar at 1Heart Caregiver Services Headquarters Los Angeles California 2
(Date:6/25/2015)... , June 25, 2015  TAKE Solutions Ltd., a ... by the United States Patent and Trademark Office (USPTO) ... process leverages TAKE Solutions, Clinical Accelerators to reduce the ... (when compared to standardization without the accelerators), thus reducing ... At the heart of the patented ...
(Date:6/24/2015)... SAN JOSE, Calif. , June 24, 2015 ... leading developer of human interface solutions, today announced ... fingerprint sensor to provide secure authentication for its ... Having recently reached more than 200 million shipments ... shipment with Sharp reinforces Synaptics, strength, scalability and ...
(Date:6/23/2015)... June 23, 2015   MedNet Solutions , ... the entire spectrum of clinical research, is pleased ... ™ , the company,s intuitive, flexible and affordable ... Silver 2015 Stevie® Award by the American ... Services Website category.  The American Business Awards are ...
Breaking Biology News(10 mins):TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2MedNet Solutions' iMedNet eClinical Wins Silver Stevie Award 2
Other TagsOther Tags